Your browser doesn't support javascript.
loading
Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer.
Zorzi, Manuel; Battagello, Jessica; Selby, Kevin; Capodaglio, Giulia; Baracco, Susanna; Rizzato, Silvia; Chinellato, Enrico; Guzzinati, Stefano; Rugge, Massimo.
Afiliação
  • Zorzi M; Veneto Tumour Registry, Azienda Zero, Padova, Italy manuel.zorzi@azero.veneto.it.
  • Battagello J; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
  • Selby K; Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
  • Capodaglio G; Screening and Health Impact Assessment Unit, Azienda Zero, Padova, Italy.
  • Baracco S; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
  • Rizzato S; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
  • Chinellato E; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
  • Guzzinati S; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
  • Rugge M; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
Gut ; 71(3): 561-567, 2022 03.
Article em En | MEDLINE | ID: mdl-33789965
BACKGROUND: The risk of colorectal cancer (CRC) among subjects with a positive faecal immunochemical test (FIT) who do not undergo a colonoscopy is unknown. We estimated whether non-compliance with colonoscopy after a positive FIT is associated with increased CRC incidence and mortality. METHODS: The FIT-based CRC screening programme in the Veneto region (Italy) invited persons aged 50 to 69 years with a positive FIT (>20 µg Hb/g faeces) for diagnostic colonoscopy at an endoscopic referral centre. In this retrospective cohort study, we compared the 10-year cumulative CRC incidence and mortality among FIT positives who completed a diagnostic colonoscopy within the programme (compliers) and those who did not (non-compliers), using the Kaplan-Meier estimator and Cox-Aalen models. RESULTS: Some 88 013 patients who were FIT positive complied with colonoscopy (males: 56.1%; aged 50-59 years: 49.1%) while 23 410 did not (males: 54.6%; aged 50-59 years: 44.9%).The 10-year cumulative incidence of CRC was 44.7 per 1000 (95% CI, 43.1 to 46.3) among colonoscopy compliers and 54.3 per 1000 (95% CI, 49.9 to 58.7) in non-compliers, while the cumulative mortality for CRC was 6.8 per 1000 (95% CI, 5.9 to 7.6) and 16.0 per 1000 (95% CI, 13.1 to 18.9), respectively. The risk of dying of CRC among non-compliers was 103% higher than among compliers (adjusted HR, 2.03; 95% CI, 1.68 to 2.44). CONCLUSION: The excess risk of CRC death among those not completing colonoscopy after a positive faecal occult blood test should prompt screening programmes to adopt effective interventions to increase compliance in this high-risk population.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Colonoscopia / Cooperação do Paciente Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Colonoscopia / Cooperação do Paciente Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article